PM BUZZ Report

Through our partnership with Diaceutics, we are pleased to offer the Personalized Medicine (PM) Buzz.

Compiled and curated from top global resources, the PM Buzz is a monthly snapshot of:

  • The latest news
  • Industry developments
  • Headline stories in the world of personalized (precision) medicine.

 

What’s happening in the PM industry…

  • NICE flip-flops to back Bristol-Myers’ Opdivo in head and neck cancer despite data ‘uncertainties’ read on…
  • Ignyta NSCLC durability data set stage for Pfizer fight read on…
  • AstraZeneca’s Lynparza ups the ante at the PARP table with FDA’s speedy breast cancer review read on…
  • Australia: Genetic testing for patients with high risk of breast, ovarian cancer now free read on…
  • Foundation Medicine receives approval from the state of New York for its FoundationACT liquid biopsy assay read on…

Subscribe to receive future PM Buzz Reports.

 

Learn More About Diaceutics

Diaceutics is a global group of experts from the laboratory, diagnostic and pharmaceutical industries with the goal of helping pharmaceutical companies integrate diagnostic testing into their treatment pathways. Diaceutics is empowered through a real-time flow of testing data from their worldwide laboratory network which they use to help their pharma clients understand and leverage the diagnostic landscape. Learn more about Diaceutics.